Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership

All NewsSeptember 17, 2025

Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent